ATP-P2X7R axis
development of P2X7R antagonists
epilepsy patients
pathological P2X7R activation
developed P2X7R antagonists
cell-specific disease contribution of P2X7R
epilepsy clinicians
drug-refractory epilepsy Current epilepsy therapies
ATP release
disease progression
brain tissue
ATP-gated P2X7 receptor
development available
significant contribution
cell types
research project
promising target
research independence
rodent models
animal models
human tissue
understanding of neuroinflammatory processes
excellent training record
sustained glial activation
temporal resolution
outstanding resources
increased hyperexcitability states
supervisor
host institution
learning
impact
new transgenic mouse lines
high sensitivity
industrial partners
mediating excitation
answers
team of experts
purinergic signalling
RCSI
inhibition
urgent need
anticonvulsant
subcellular expression
different mechanisms of action
exciting concept
network changes
tools necessary
important gaps
intersectoral approach
disorders
clinical application
properties
seizures
Recent technical advances
CNS
Evidence
gatekeeper of inflammation
questions
reach
EpiPur
results
skills
Biosensors